Nisa Investment Advisors LLC Decreases Position in Cooper Companies, Inc. (The) (COO)

Nisa Investment Advisors LLC decreased its stake in Cooper Companies, Inc. (The) (NYSE:COO) by 14.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 32,110 shares of the medical device company’s stock after selling 5,400 shares during the period. Nisa Investment Advisors LLC owned about 0.07% of Cooper Companies, Inc. (The) worth $7,688,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the stock. YorkBridge Wealth Partners LLC boosted its stake in shares of Cooper Companies, Inc. (The) by 18.5% in the first quarter. YorkBridge Wealth Partners LLC now owns 520 shares of the medical device company’s stock valued at $105,000 after buying an additional 81 shares during the last quarter. Archford Capital Strategies LLC boosted its stake in shares of Cooper Companies, Inc. (The) by 116.7% in the first quarter. Archford Capital Strategies LLC now owns 674 shares of the medical device company’s stock valued at $135,000 after buying an additional 363 shares during the last quarter. Penserra Capital Management LLC boosted its stake in shares of Cooper Companies, Inc. (The) by 9.5% in the first quarter. Penserra Capital Management LLC now owns 782 shares of the medical device company’s stock valued at $156,000 after buying an additional 68 shares during the last quarter. Pacer Advisors Inc. boosted its stake in shares of Cooper Companies, Inc. (The) by 3.8% in the first quarter. Pacer Advisors Inc. now owns 848 shares of the medical device company’s stock valued at $170,000 after buying an additional 31 shares during the last quarter. Finally, Dai Ichi Life Insurance Company Ltd acquired a new stake in shares of Cooper Companies, Inc. (The) during the first quarter valued at approximately $206,000. Institutional investors and hedge funds own 99.97% of the company’s stock.

Shares of Cooper Companies, Inc. (NYSE COO) traded up 0.39% during mid-day trading on Friday, reaching $240.92. 286,217 shares of the company traded hands. Cooper Companies, Inc. has a 52-week low of $158.73 and a 52-week high of $256.39. The firm’s 50 day moving average price is $245.14 and its 200-day moving average price is $214.89. The company has a market capitalization of $11.77 billion, a P/E ratio of 36.12 and a beta of 0.61.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its quarterly earnings data on Thursday, June 1st. The medical device company reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.25 by $0.25. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The business had revenue of $522.40 million during the quarter, compared to analysts’ expectations of $520.71 million. During the same period in the previous year, the firm earned $2.05 earnings per share. The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. Equities analysts predict that Cooper Companies, Inc. will post $9.63 earnings per share for the current fiscal year.

The company also recently declared a semiannual dividend, which was paid on Monday, August 7th. Stockholders of record on Friday, July 21st were issued a $0.03 dividend. The ex-dividend date was Wednesday, July 19th. This represents a dividend yield of 0.02%. Cooper Companies, Inc. (The)’s dividend payout ratio (DPR) is 0.90%.

ILLEGAL ACTIVITY NOTICE: “Nisa Investment Advisors LLC Decreases Position in Cooper Companies, Inc. (The) (COO)” was reported by BNB Daily and is the property of of BNB Daily. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at https://www.baseball-news-blog.com/2017/08/13/cooper-companies-inc-the-coo-stake-decreased-by-nisa-investment-advisors-llc-updated-updated-updated.html.

Several equities analysts recently issued reports on COO shares. Zacks Investment Research lowered shares of Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a report on Thursday, June 1st. BidaskClub lowered shares of Cooper Companies, Inc. (The) from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. Piper Jaffray Companies upped their target price on shares of Cooper Companies, Inc. (The) to $265.00 and gave the stock an “overweight” rating in a report on Wednesday, July 19th. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies, Inc. (The) in a report on Friday, July 21st. Finally, J P Morgan Chase & Co reaffirmed a “neutral” rating and set a $206.00 target price (up previously from $200.00) on shares of Cooper Companies, Inc. (The) in a report on Monday, June 5th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $242.00.

In related news, CEO Paul L. Remmell sold 9,294 shares of the company’s stock in a transaction dated Friday, July 14th. The stock was sold at an average price of $248.46, for a total transaction of $2,309,187.24. Following the sale, the chief executive officer now owns 6,186 shares in the company, valued at $1,536,973.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Carol R. Kaufman sold 44,092 shares of the company’s stock in a transaction dated Thursday, June 8th. The stock was sold at an average price of $242.81, for a total value of $10,705,978.52. Following the sale, the executive vice president now owns 60,419 shares in the company, valued at approximately $14,670,337.39. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 67,331 shares of company stock worth $16,400,454. Corporate insiders own 1.60% of the company’s stock.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply